Sage Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGE THERAP, and when can generic versions of SAGE THERAP drugs launch?
SAGE THERAP has one approved drug.
There are eight US patents protecting SAGE THERAP drugs.
There are one hundred and seventeen patent family members on SAGE THERAP drugs in thirty-one countries.
Summary for Sage Therap
| International Patents: | 117 |
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sage Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therap | ZULRESSO | brexanolone | SOLUTION;INTRAVENOUS | 211371-001 | Jun 17, 2019 | RX | Yes | Yes | 9,200,088 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Sage Therap | ZULRESSO | brexanolone | SOLUTION;INTRAVENOUS | 211371-001 | Jun 17, 2019 | RX | Yes | Yes | 9,750,822 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Sage Therap | ZULRESSO | brexanolone | SOLUTION;INTRAVENOUS | 211371-001 | Jun 17, 2019 | RX | Yes | Yes | 10,940,156 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sage Therap | ZULRESSO | brexanolone | SOLUTION;INTRAVENOUS | 211371-001 | Jun 17, 2019 | RX | Yes | Yes | 10,322,139 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sage Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2023093723 | ⤷ Subscribe |
| New Zealand | 627781 | ⤷ Subscribe |
| Cyprus | 1122527 | ⤷ Subscribe |
| Morocco | 43815 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
